United Kingdom
Devi Pathak is an Imperial College London graduate in BSc Medical Biosciences and a current graduate entry MBBS student at the University of Southampton. Her academic and translational research interests span cardiovascular biology, pharmacology, and neuroscience, with a particular focus on the interface between molecular science and clinical innovation. As the founder of PulmoGuard, a health tech venture developing a novel breathalyser for the early detection of lung cancer, Devi combines scientific insight with entrepreneurial drive to advance precision diagnostics. She has been recognised as a Verizon Young Entrepreneur Finalist and an AstraZeneca Young Health Impact Fellow, distinctions that reflect her commitment to bridging biomedical research with global health impact.
- PulmoGuard is a start-up developing a diagnostic tool for non-invasive lung cancer detection via analysis of biomarkers in exhaled breath. - Selected as a finalist for the European Young Entrepreneurs challenge, receiving an £1000 seed grant and tailored masterclasses with Verizon.
- Led on-ground community outreach, engaging directly with the public to recruit eligible participants for women’s health and fertility research. - Communicated the importance of reproductive health innovation, building awareness of Genie’s mission to make fertility diagnostics more accessible and data-driven.
- Conducted analysis of menstrual blood samples to identify and study biomarkers related to fertility and reproductive health. - Supported patient recruitment and coordination for biological sample collection and data management.